HDAC inhibitor depletes latent HIV

Researchers published in The Lancet that the HDAC inhibitor valproic acid depleted latent HIV infection in resting CD4+ T cells following HAART plus Fuzeon enfurvitide from Trimeris (TRMS) and Roche ...